Tracking humoral responses using self assembling protein microarrays

The humoral immune response is a highly specific and adaptive sensor for changes in the body's protein milieu, which responds to novel structures of both foreign and self antigens. Although Igs represent a major component of human serum and are vital to survival, little is known about the response specificity and determinants that govern the human immunome. Historically, antigen‐specific humoral immunity has been investigated using individually produced and purified target proteins, a labor‐intensive process that has limited the number of antigens that have been studied. Here, we present the development of methods for applying self‐assembling protein microarrays and a related method for producing 96‐well formatted macroarrays for monitoring the humoral response at the proteome scale. Using plasmids encoding full‐length cDNAs for over 850 human proteins and 1700 pathogen proteins, we demonstrate that these microarrays are highly sensitive, specific, reproducible, and can simultaneously measure immunity to thousands of proteins without a priori protein purification. Using this approach, we demonstrate the detection of humoral immunity to known and novel self‐antigens, cancer antigens, autoimmune antigens, as well as pathogen‐derived antigens. This represents a powerful and versatile tool for monitoring the immunome in health and disease.

[1]  P. Bingley,et al.  Proposed guidelines on screening for risk of type 1 diabetes. , 2001, Diabetes care.

[2]  Christophe Benoist,et al.  A Plaidoyer for ‘Systems Immunology’ , 2006, Immunological reviews.

[3]  A. Notkins New predictors of disease , 2007 .

[4]  Gil Mor,et al.  Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays , 2007, Proceedings of the National Academy of Sciences.

[5]  P. Bingley,et al.  Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. , 2004, Diabetes.

[6]  A. Notkins New predictors of disease. Molecules called predictive autoantibodies appear in the blood years before people show symptoms of various disorders. Tests that detected these molecules could warn of the need to take preventive action. , 2007, Scientific American.

[7]  Pierre Baldi,et al.  Immunodominant Francisella tularensis antigens identified using proteome microarray. ©Crown Copyright 2007 Dstl , 2007, Proteomics.

[8]  G. Poland Acellular pertussis vaccines: new vaccines for an old disease , 1996, The Lancet.

[9]  Yanhui Hu,et al.  Next generation high density self assembling functional protein arrays , 2008, Nature Methods.

[10]  Jianjun Yu,et al.  Autoantibody Signatures in Prostate Cancer , 2006 .

[11]  Bhupinder Bhullar,et al.  Self-Assembling Protein Microarrays , 2004, Science.

[12]  Dieter Stoll,et al.  A microarray enzyme‐linked immunosorbent assay for autoimmune diagnostics , 2000, Electrophoresis.

[13]  E. Gale European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes , 2004, The Lancet.

[14]  P. Brown,et al.  Autoantigen microarrays for multiplex characterization of autoantibody responses , 2002, Nature Medicine.

[15]  Igor Goychuk,et al.  Optimal Design of Microarray Immunoassays to Compensate for Kinetic Limitations , 2006, Molecular & Cellular Proteomics.

[16]  Gerard Tromp,et al.  Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. , 2006, Cancer research.

[17]  James A Koziol,et al.  Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  Yao-Tseng Chen,et al.  A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Trkola,et al.  Humoral immunity to HIV‐1: neutralization and beyond , 2007, Journal of internal medicine.

[20]  S. M. Hewitt,et al.  Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[21]  S. Crotty,et al.  Immunity and immunological memory following smallpox vaccination , 2006, Immunological reviews.

[22]  C. Meisner,et al.  A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients , 2007, Proceedings of the National Academy of Sciences.

[23]  P. Bingley,et al.  Prediction of IDDM in the General Population: Strategies Based on Combinations of Autoantibody Markers , 1997, Diabetes.

[24]  David E. Misek,et al.  Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. , 2004, Journal of proteome research.

[25]  M. Taussig,et al.  DiscernArray technology: a cell-free method for the generation of protein arrays from PCR DNA. , 2003, Journal of immunological methods.

[26]  M. A. Bopp,et al.  Zeptosens' protein microarrays: A novel high performance microarray platform for low abundance protein analysis , 2002, Proteomics.

[27]  Joshua LaBaer,et al.  The sentinel within: exploiting the immune system for cancer biomarkers. , 2005, Journal of proteome research.

[28]  L. Saiman Microbiology of early CF lung disease. , 2004, Paediatric respiratory reviews.

[29]  C. Benoist,et al.  Back to central tolerance. , 2004, Immunity.

[30]  C. Janeway Immunobiology: The Immune System in Health and Disease , 1996 .

[31]  M. Atkinson,et al.  Type 1 diabetes: new perspectives on disease pathogenesis and treatment , 2001, The Lancet.

[32]  M. Pawlak,et al.  Functional immobilization of biomembrane fragments on planar waveguides for the investigation of side-directed ligand binding by surface-confined fluorescence. , 1998, Faraday discussions.

[33]  M. Carroll,et al.  Monitoring of human immunological responses to vaccinia virus. , 2004, Methods in molecular biology.

[34]  M. Taussig,et al.  Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method). , 2001, Nucleic acids research.

[35]  M. Boscaro,et al.  II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. , 1997, The Journal of clinical endocrinology and metabolism.

[36]  Andreas Radbruch,et al.  Antibodies and B cell memory in viral immunity. , 2007, Immunity.

[37]  G. Cooper,et al.  The epidemiology of autoimmune diseases. , 2003, Autoimmunity reviews.

[38]  P. Brown,et al.  Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions , 2001, Genome Biology.

[39]  A. Mawson,et al.  SET-related Cell Division Autoantigen-1 (CDA1) Arrests Cell Growth* , 2001, The Journal of Biological Chemistry.